Becton Dickinson and Company (BDX) is a Healthcare · Medical Instruments & Supplies company listed on NYSE. Price $180.94 (-0.24%), Market cap $39.73B, P/E ratio 25.21, 52-week low–high $143.15 ~ $210.02.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, h
Financial statements, price targets, institutional (13F) holdings and related news for Becton Dickinson and Company are updated in real time on BlackAll Trade.
Becton Dickinson and Company trades at $180.94 (-0.24%). Real-time quotes and charts are available on BlackAll Trade.
Becton Dickinson and Company has a market cap of about $39.73B. Its P/E ratio is 25.21.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researche